Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer.
Authors: Tsoi, Ho1 (AUTHOR), Leung, George Man Hong1 (AUTHOR), Man, Ellen Pui Sum1 (AUTHOR), You, Chan Ping1 (AUTHOR), Cheung, Koei Ho Lam1 (AUTHOR), Chan, Kelvin Yuen Kwong2 (AUTHOR), Gong, Chun3 (AUTHOR), Huen, Michael Shing Yan4 (AUTHOR), Khoo, Ui Soon1 (AUTHOR) uskhoo@hku.hk
Source: Journal of Translational Medicine. 8/5/2025, Vol. 23 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-025-06902-8